Literature DB >> 18005033

Interleukin (IL)-4 promotes T helper type 2-biased natural killer T (NKT) cell expansion, which is regulated by NKT cell-derived interferon-gamma and IL-4.

Akira Iizuka1, Yoshinori Ikarashi, Mitsuzi Yoshida, Yuji Heike, Kazuyoshi Takeda, Gary Quinn, Hiro Wakasugi, Masanobu Kitagawa, Yoichi Takaue.   

Abstract

CD1d-restricted natural killer T (NKT) cells can rapidly produce T helper type 1 (Th1) and Th2 cytokines and also play regulatory or pathological roles in immune responses. NKT cells are able to expand when cultured with alpha-galactosylceramide (alpha-GalCer) and interleukin (IL)-2 in a CD1d-restricted manner. However, the expansion ratio of human NKT cells is variable from sample to sample. In this study, we sought to determine what factor or factors are responsible for efficient in vitro expansion of NKT cells from various inbred mouse strains. Although the proportion of NKT cells in the spleen was nearly identical in each mouse strain, the growth rates of NKT cells cultured in vitro with alpha-GalCer and IL-2 were highly variable. NKT cells from the B6C3F1 and BDF1 mouse strains expanded more than 20-fold after 4 days in culture. In contrast, NKT cells from the strain C3H/HeN did not proliferate at all. We found that cell expansion efficiency correlated with the level of IL-4 detectable in the supernatant after culture. Furthermore, we found that exogenous IL-4 augmented NKT cell proliferation early in the culture period, whereas interferon (IFN)-gamma tended to inhibit NKT cell proliferation. Thus, the ratio of production of IL-4 and IFN-gamma was important for NKT cell expansion but the absolute levels of these cytokines did not affect expansion. This finding suggests that effective expansion of NKT cells requires Th2-biased culture conditions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18005033      PMCID: PMC2433277          DOI: 10.1111/j.1365-2567.2007.02732.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  45 in total

Review 1.  Natural killer T cell-mediated antitumor immune responses and their clinical applications.

Authors:  Ken-ichiro Seino; Shinichiro Motohashi; Takehiko Fujisawa; Toshinori Nakayama; Masaru Taniguchi
Journal:  Cancer Sci       Date:  2006-06-29       Impact factor: 6.716

2.  CD1d-restricted NKT cell activation enhanced homeostatic proliferation of CD8+ T cells in a manner dependent on IL-4.

Authors:  Naoko Ueda; Hiroko Kuki; Daisuke Kamimura; Shinichiro Sawa; Kenichiro Seino; Takuya Tashiro; Ken-ichi Fushuku; Masaru Taniguchi; Toshio Hirano; Masaaki Murakami
Journal:  Int Immunol       Date:  2006-08-16       Impact factor: 4.823

3.  Chemotherapy pretreatment sensitizes solid tumor-derived cell lines to V alpha 24+ NKT cell-mediated cytotoxicity.

Authors:  Stephen R Mattarollo; Tony Kenna; Mie Nieda; Andrew J Nicol
Journal:  Int J Cancer       Date:  2006-10-01       Impact factor: 7.396

4.  Expansion of alpha-galactosylceramide-stimulated Valpha24+ NKT cells cultured in the absence of animal materials.

Authors:  Yukie Harada; Osamu Imataki; Yuji Heike; Hiroyuki Kawai; Akihiro Shimosaka; Shin-ichiro Mori; Masahiro Kami; Ryuji Tanosaki; Yoshinori Ikarashi; Akira Iizuka; Mitsuji Yoshida; Hiro Wakasugi; Shigeru Saito; Yoichi Takaue; Masao Takei; Tadao Kakizoe
Journal:  J Immunother       Date:  2005 Jul-Aug       Impact factor: 4.456

5.  Human natural killer T cells acquire a memory-activated phenotype before birth.

Authors:  H J van Der Vliet; N Nishi; T D de Gruijl; B M von Blomberg; A J van den Eertwegh; H M Pinedo; G Giaccone; R J Scheper
Journal:  Blood       Date:  2000-04-01       Impact factor: 22.113

6.  Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections.

Authors:  Jochen Mattner; Kristin L Debord; Nahed Ismail; Randal D Goff; Carlos Cantu; Dapeng Zhou; Pierre Saint-Mezard; Vivien Wang; Ying Gao; Ning Yin; Kasper Hoebe; Olaf Schneewind; David Walker; Bruce Beutler; Luc Teyton; Paul B Savage; Albert Bendelac
Journal:  Nature       Date:  2005-03-24       Impact factor: 49.962

7.  Synergistic effect of KRN7000 with interleukin-15, -7, and -2 on the expansion of human V alpha 24+V beta 11+ T cells in vitro.

Authors:  N Nishi; H J van der Vliet; Y Koezuka; B M von Blomberg; R J Scheper; H M Pinedo; G Giaccone
Journal:  Hum Immunol       Date:  2000-04       Impact factor: 2.850

8.  Human invariant valpha24+ natural killer T cells activated by alpha-galactosylceramide (KRN7000) have cytotoxic anti-tumour activity through mechanisms distinct from T cells and natural killer cells.

Authors:  A Nicol; M Nieda; Y Koezuka; S Porcelli; K Suzuki; K Tadokoro; S Durrant; T Juji
Journal:  Immunology       Date:  2000-02       Impact factor: 7.397

9.  The Pro-Th1 cytokine IL-12 enhances IL-4 production by invariant NKT cells: relevance for T cell-mediated hepatitis.

Authors:  Ren Zhu; Séverine Diem; Luiza M Araujo; Aude Aumeunier; Jordan Denizeau; Emilie Philadelphe; Diane Damotte; Michel Samson; Pierre Gourdy; Michel Dy; Elke Schneider; André Herbelin
Journal:  J Immunol       Date:  2007-05-01       Impact factor: 5.422

10.  Differential tumor surveillance by natural killer (NK) and NKT cells.

Authors:  M J Smyth; K Y Thia; S E Street; E Cretney; J A Trapani; M Taniguchi; T Kawano; S B Pelikan; N Y Crowe; D I Godfrey
Journal:  J Exp Med       Date:  2000-02-21       Impact factor: 14.307

View more
  3 in total

1.  Diverse roles of natural killer T lymphocytes in liver and spleen in mice with experimental autoimmune uveitis.

Authors:  Shengya Zhao; Dadong Guo; Hongsheng Bi; Yan Cui; Xiaofeng Xie; Xingrong Wang; Jiao Li
Journal:  Inflammation       Date:  2014-04       Impact factor: 4.092

2.  Invariant NKT cell activation induces neutrophil accumulation and hepatitis: opposite regulation by IL-4 and IFN-γ.

Authors:  Hua Wang; Dechun Feng; Ogyi Park; Shi Yin; Bin Gao
Journal:  Hepatology       Date:  2013-08-06       Impact factor: 17.425

3.  Identification of distinct human invariant natural killer T-cell response phenotypes to alpha-galactosylceramide.

Authors:  Joanne E Croudace; Stuart M Curbishley; Manuela Mura; Carrie R Willcox; Petr A Illarionov; Gurdyal S Besra; David H Adams; David A Lammas
Journal:  BMC Immunol       Date:  2008-12-03       Impact factor: 3.615

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.